Founding date
1992-05-27
Registered capital
80,870,000 RMB
Employees
200-500
Industry
Genetically engineered drugs and vaccine manufacturing
Business scope: Sale, Human Immunoglobulin, Human Prothrombin Complex, Ph4, Ph4, Ph4, Production, Human Albumin, Tetanus Human Immunoglobulin, Rabies Immune Globulin, Hepatitis B Human Immunoglobulin, Lyophilized Intravenous Human Immunoglobulin, Intravenous Human Immunoglobulin, Intravenous Hepatitis B Human Immune Globulin, Blood Products, Human Fibrinogen,

Examples of data in the Chinese company database